X0306 4 2017-03-02 0001613103 Medtronic plc MDT 0001610035 HAKAMI HOOMAN 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 1 EVP & Group President Diabetes Ordinary Shares 2017-03-02 4 M 0 14871 62.76 A 73800 D Ordinary Shares 2017-03-02 4 M 0 797 62.76 A 74597 D Ordinary Shares 2017-03-02 4 M 0 36648 62.76 A 111245 D Ordinary Shares 2017-03-02 4 S 0 52316 82.327 D 58929 D Stock Option (Right to Buy) 62.76 2017-03-02 4 M 0 14871 0 D 2024-07-28 Ordinary Shares 14871 89762 D Stock Option (Right to Buy) 62.76 2017-03-02 4 M 0 797 0 D 2024-07-28 Ordinary Shares 797 88965 D Stock Option (Right to Buy) 62.76 2017-03-02 4 M 0 36648 0 D 2024-07-28 Ordinary Shares 36648 52317 D The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.30 to $82.41, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This balance increased by 627 shares due to exempt transactions such as dividend reinvestment. This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. /s/ Rhonda L. Ingalsbe, Attorney-in-fact 2017-03-06